Global Leukemia Therapeutics Market by Type (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia), Treatment Type (Chemotherapy, Targeted Drugs & Immunotherapy), Molecule Type, Mode of Administration, Gender

The Leukemia Therapeutics Market size was estimated at USD 15.64 billion in 2023, USD 16.73 billion in 2024, and is expected to grow at a CAGR of 7.02% to reach USD 25.17 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Leukemia Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leukemia Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Leukemia Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca PLC, Biogen Inc, Bristol Myers Squibb Company, Eisai Co., Ltd, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., GlaxoSmithKline PLC, Incyte Corp, Johnson & Johnson Services, Inc., Merck KGaA, Novartis International AG, Pfizer Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Leukemia Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
Treatment Type
- Chemotherapy
- Targeted Drugs & Immunotherapy
Molecule Type
- Biologics
- Small Molecules
Mode of Administration
- Injectable Mode
- Oral Mode
Gender
- Female
- Male

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Leukemia Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leukemia Therapeutics Market?
What are the technology trends and regulatory frameworks in the Leukemia Therapeutics Market?
What is the market share of the leading vendors in the Leukemia Therapeutics Market?
Which modes and strategic moves are suitable for entering the Leukemia Therapeutics Market?

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Leukemia Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of leukemia cases
5.1.1.2. Growing need for cancer therapy
5.1.1.3. Increasing investment in healthcare sector
5.1.2. Restraints
5.1.2.1. High cost of treatment and development of new therapeutics
5.1.3. Opportunities
5.1.3.1. Development of innovative diagnostic and therapeutics for leukemia patients
5.1.3.2. Expanding investments in the healthcare sector and favorable government initiatives
5.1.4. Challenges
5.1.4.1. Stringent regulatory scenario
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Leukemia Therapeutics Market, by Type

6.1. Introduction
6.2. Acute Lymphocytic Leukemia
6.3. Acute Myeloid Leukemia
6.4. Chronic Lymphocytic Leukemia
6.5. Chronic Myeloid Leukemia

7. Leukemia Therapeutics Market, by Treatment Type

7.1. Introduction
7.2. Chemotherapy
7.3. Targeted Drugs & Immunotherapy

8. Leukemia Therapeutics Market, by Molecule Type

8.1. Introduction
8.2. Biologics
8.3. Small Molecules

9. Leukemia Therapeutics Market, by Mode of Administration

9.1. Introduction
9.2. Injectable Mode
9.3. Oral Mode

10. Leukemia Therapeutics Market, by Gender

10.1. Introduction
10.2. Female
10.3. Male

11. Americas Leukemia Therapeutics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Leukemia Therapeutics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Leukemia Therapeutics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. AbbVie Inc.
15.1.2. AstraZeneca PLC
15.1.3. Biogen Inc
15.1.4. Bristol Myers Squibb Company
15.1.5. Eisai Co., Ltd
15.1.6. F. Hoffmann-La Roche AG
15.1.7. Gilead Sciences, Inc.
15.1.8. GlaxoSmithKline PLC
15.1.9. Incyte Corp
15.1.10. Johnson & Johnson Services, Inc.
15.1.11. Merck KGaA
15.1.12. Novartis International AG
15.1.13. Pfizer Inc.
15.1.14. Sanofi S.A.
15.1.15. Takeda Pharmaceutical Company Limited
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. LEUKEMIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. LEUKEMIA THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. LEUKEMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LEUKEMIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LEUKEMIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LEUKEMIA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 12. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 14. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 16. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. LEUKEMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. LEUKEMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. LEUKEMIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. LEUKEMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LEUKEMIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ACUTE LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 11. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TARGETED DRUGS & IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 14. LEUKEMIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LEUKEMIA THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 17. LEUKEMIA THERAPEUTICS MARKET SIZE, BY INJECTABLE MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ORAL MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 20. LEUKEMIA THERAPEUTICS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 38. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 65. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 70. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 110. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 115. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 131. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 136. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 146. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 156. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 171. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 176. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 181. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 201. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 211. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 216. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 231. LEUKEMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 232. LEUKEMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 233. LEUKEMIA THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
AstraZeneca PLC
Biogen Inc
Bristol Myers Squibb Company
Eisai Co., Ltd
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Incyte Corp
Johnson & Johnson Services, Inc.
Merck KGaA
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 16.73 Billion
Forecasted Market Value ( USD ) by 2030	$ 25.17 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3712EUR$3,939USD£3,107GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4664EUR$4,949USD£3,904GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6568EUR$6,969USD£5,497GBP

Global Leukemia Therapeutics Market by Type (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia), Treatment Type (Chemotherapy, Targeted Drugs & Immunotherapy), Molecule Type, Mode of Administration, Gender - Forecast 2024-2030

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Leukemia Therapeutics Global Market Report 2024

North America Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Country and Growth Forecast, 2023 - 2029

Asia Pacific Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Country and Growth Forecast, 2023 - 2029

Leukemia Therapeutics - Global Strategic Business Report

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024